<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: sutent</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Protein central to cancer stem cell formation provides new potential target</title>
   	 <description>Researchers have identified a pivotal protein in a cellular transformation that makes a cancer cell more resistant to treatment and more capable of growing and spreading, making it an inviting new target for drug development.</description>
     <link>http://medicalxpress.com/news/2013-02-protein-central-cancer-stem-cell.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 13 Feb 2013 14:30:01 EST</pubDate>
	 <guid isPermaLink="false">news279987024</guid>
	 
</item>
<item>
     <title>Drug targets hard-to-reach leukemia stem cells responsible for relapses</title>
   	 <description>Researchers at the University of California, San Diego School of Medicine have discovered that hard-to-reach, drug-resistant leukemia stem cells (LSCs) that overexpress multiple pro-survival protein forms are sensitive – and thus vulnerable – to a novel cancer stem cell-targeting drug currently under development.</description>
     <link>http://medicalxpress.com/news/2013-01-drug-hard-to-reach-leukemia-stem-cells.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 17 Jan 2013 12:00:18 EST</pubDate>
	 <guid isPermaLink="false">news277642727</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/drugtargetsh.jpg" width="90" height="90" />
</item>
<item>
     <title>New drug overcomes resistance in patients with rare sarcoma</title>
   	 <description>A new targeted drug demonstrated its ability to control metastatic gastrointestinal stromal tumor, an uncommon and life-threatening form of sarcoma, after the disease had become resistant to all existing therapies, report investigators at Dana-Farber Cancer Institute who led the worldwide clinical trial.</description>
     <link>http://medicalxpress.com/news/2012-11-drug-resistance-patients-rare-sarcoma.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 21 Nov 2012 18:30:09 EST</pubDate>
	 <guid isPermaLink="false">news272740107</guid>
	 
</item>
<item>
     <title>Long-term side effects key when cancer patients choose drugs</title>
   	 <description>(HealthDay) -- Long-term medication side effects such as fatigue can be key for patients deciding which cancer drug to take, new research suggests.</description>
     <link>http://medicalxpress.com/news/2012-06-long-term-side-effects-key-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Sat, 02 Jun 2012 14:00:01 EST</pubDate>
	 <guid isPermaLink="false">news257862311</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/longtermside.jpg" width="90" height="90" />
</item>
<item>
     <title>Three 'targeted' cancer drugs raise risk of fatal side effects</title>
   	 <description>Treatment with three relatively new &quot;targeted&quot; cancer drugs has been linked to a slightly elevated chance of fatal side effects, according to a new analysis led by scientists at Dana-Farber Cancer Institute. They added that the risk remains low, but should be taken into account by physicians and patients.</description>
     <link>http://medicalxpress.com/news/2012-02-cancer-drugs-fatal-side-effects.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 06 Feb 2012 16:00:20 EST</pubDate>
	 <guid isPermaLink="false">news247755859</guid>
	 
</item>
<item>
     <title>Avastin, Sutent increase breast cancer stem cells, study shows</title>
   	 <description>Cancer treatments designed to block the growth of blood vessels were found to increase the number of cancer stem cells in breast tumors in mice, suggesting a possible explanation for why these drugs don't lead to longer survival, according to a new study by researchers at the University of Michigan Comprehensive Cancer Center.</description>
     <link>http://medicalxpress.com/news/2012-01-avastin-sutent-breast-cancer-stem.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 25 Jan 2012 09:31:17 EST</pubDate>
	 <guid isPermaLink="false">news246706261</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/avastinsuten.jpg" width="90" height="90" />
</item>


</channel>
</rss>
